High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years?
Sondel PM, Rakhmilevich AL, Ansari IH, Erbe AK.J Immunother Cancer. 2025 Oct 31;13(10):e013267. doi: 10.1136/jitc-2025-013267.PMID: 41176314 Free article. Review.
Deep learning-based PSMA PET segmentation repeatability: A post-hoc analysis of a single-center, prospective, test-retest trial.
Kendrick J, Francis RJ, Hassan GM, Ong JSL, Jeraj R, Barry N, Ebert MA.Radiol Med. 2025 Oct 30. doi: 10.1007/s11547-025-02137-1. Online ahead of print.PMID: 41166032
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.
Lesperance J, Yung BS, Allevato MM, Cheng MM, Camargo MF, Saddawi-Konefka R, Dhawan K, Sharma AK, Mortaja M, Bice S, Scanderbeg DJ, Alvarado D, Mayadev J, Eskander RN, Adams SR, Cosper PF, Gutkind JS, Advani SJ.Adv Sci (Weinh). 2025 Oct 24:e06552. doi: 10.1002/advs.202506552. Online ahead of print.PMID: 41133986
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels.
Helzer KT, Sharifi MN, Sperger JM, Chrostek MR, Bootsma ML, Reese SR, Taylor A, Kaufmann KR, Krause H, Schehr J, Sethakorn N, Kosoff D, Kyriakopoulos CE, Bassetti M, Blitzer G, Floberg J, Sjöström M, Armstrong AJ, Beltran H, McKay RR, Feng FY, O’Regan R, Wisinski KB, Emamekhoo H, Wyatt AW, Lang JM, Zhao SG.Nat Commun. 2025 Oct 14;16(1):9122. doi: 10.1038/s41467-025-64153-z.PMID: 41087333 Free PMC article.
Evaluation of a novel quantitative multiparametric MR sequence for radiation therapy treatment response assessment.
Yan Y, Bayliss RA, Burr AR, Baschnagel AM, Morris BA, Wiesinger F, Rodriguez JA, Glide-Hurst CK.J Appl Clin Med Phys. 2025 Oct;26(10):e70274. doi: 10.1002/acm2.70274.PMID: 41057999 Free PMC article.
Bragg-peak FLASH biological optimization enables enhanced normal tissue sparing and dose escalation for ocular stereotactic body radiation therapy.
Hamza M, Selvaraj B, Cheng C, Zhao X, Kaulfers T, Lattery G, Zhai H, Simone Ii CB, Barker C, Chang J, Lin H, Kang M.Phys Med Biol. 2025 Oct 27;70(21). doi: 10.1088/1361-6560/ae0ef7.PMID: 41038240
First experience with third-party validations: A robust calibration and QA procedure for proton FLASH delivery.
Chang CC, Selvaraj B, Zhao X, Rembish J, Taylor PA, Bookbinder A, Cheng C, Choi JI, Simone CB 2nd, Lin H, Kang M.J Appl Clin Med Phys. 2025 Oct;26(10):e70269. doi: 10.1002/acm2.70269.PMID: 41014172 Free PMC article.
Severe Late Toxicities (Grade 3-5) With 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy.
Ranta K, Wojcieszynski AP, Zhao SG, Liu Y, Jarrard DF, Yu M, Huenerberg K, Hutten R, Cooley G, Kruser TJ, Ritter MA, Floberg JM.Int J Radiat Oncol Biol Phys. 2025 Oct 1;123(2):374-380. doi: 10.1016/j.ijrobp.2025.04.002. Epub 2025 Apr 12.PMID: 40222393